Detailed TOC of Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
1.1 Product Overview and Scope of Beta-Nicotinamide Mononucleotide (NMN)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2019 Versus 2023 Versus 2032
1.3.2 Content Greater than or Equal to 98%
1.3.3 Content Less than 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2019 Versus 2023 Versus 2032
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019 & 2023 & 2032)
1.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2019-2032)
1.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (2019-2032)
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kingdomway Recent Developments/Updates
3 Competitive Environment: Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2024)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
3.4.2 Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
3.5 Beta-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
3.5.1 Beta-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
3.5.2 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
3.5.3 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2032)
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2032)
4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2032)
4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2032)
4.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2032)
4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2032)
4.5 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2032)
4.6 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2032)
5 Market Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2032)
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2019-2032)
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2032)
6 Market Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2032)
6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2019-2032)
6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2032)
7 North America
7.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2032)
7.2 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2032)
7.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2032)
7.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2032)
7.3.3 United States Market Size and Forecast (2019-2032)
7.3.4 Canada Market Size and Forecast (2019-2032)
7.3.5 Mexico Market Size and Forecast (2019-2032)
8 Europe
8.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2032)
8.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2032)
8.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2032)
8.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2032)
8.3.3 Germany Market Size and Forecast (2019-2032)
8.3.4 France Market Size and Forecast (2019-2032)
8.3.5 United Kingdom Market Size and Forecast (2019-2032)
8.3.6 Russia Market Size and Forecast (2019-2032)
8.3.7 Italy Market Size and Forecast (2019-2032)
9 Asia-Pacific
9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2032)
9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2032)
9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2032)
9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2032)
9.3.3 China Market Size and Forecast (2019-2032)
9.3.4 Japan Market Size and Forecast (2019-2032)
9.3.5 Korea Market Size and Forecast (2019-2032)
9.3.6 India Market Size and Forecast (2019-2032)
9.3.7 Southeast Asia Market Size and Forecast (2019-2032)
9.3.8 Australia Market Size and Forecast (2019-2032)
10 South America
10.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2032)
10.2 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2032)
10.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2032)
10.3.2 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2032)
10.3.3 Brazil Market Size and Forecast (2019-2032)
10.3.4 Argentina Market Size and Forecast (2019-2032)
11 Middle East & Africa
11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2032)
11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2032)
11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2032)
11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2032)
11.3.3 Turkey Market Size and Forecast (2019-2032)
11.3.4 Egypt Market Size and Forecast (2019-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2032)
11.3.6 South Africa Market Size and Forecast (2019-2032)
12 Market Dynamics
12.1 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
12.2 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
12.3 Beta-Nicotinamide Mononucleotide (NMN) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Beta-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide (NMN)
13.3 Beta-Nicotinamide Mononucleotide (NMN) Production Process
13.4 Beta-Nicotinamide Mononucleotide (NMN) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
14.3 Beta-Nicotinamide Mononucleotide (NMN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
